MedPath

Effectivity and Safety Study of Trans-artificial-urethral Resection of Female Urethral Caruncle

Not Applicable
Conditions
Urethral Caruncle
Registration Number
NCT02490228
Lead Sponsor
Peking University First Hospital
Brief Summary

To explore the minimally invasive and exhaustive treatment of female urethral canruncle by using trans-artificial-urethral resection of the canruncle. The investigators plant to recruit patients using this surgical method and study the effectivity of this method.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • patient with urethral caruncle
Exclusion Criteria
  • recurrence urethral caruncle

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Operative timeUp to 6 months
Length of hospital stayUp to 6 months
Estimated blood lossUp to 6 months
pathological typeUp to 6 months
Complication incidence rateUp to 6 months
Secondary Outcome Measures
NameTimeMethod
recurrence-free survivalUp to 12 months

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.